+77.2%
CME vs EMR
+62.8%
+14.4%
-31.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | -0.4% | -0.6% | -1.1% |
| 7D | -2.9% | +3.1% | -5.9% | -3.1% |
| 30D | +5.5% | -3.5% | +9.1% | +5.7% |
| 3M | +11.0% | +9.8% | +1.2% | +10.0% |
| 6M | -9.7% | +10.8% | -20.5% | -10.7% |
| YTD | +4.9% | +15.9% | -11.1% | +3.2% |
| 1Y | +10.1% | +16.4% | -6.3% | +8.1% |
| 3Y | +53.5% | +62.1% | -8.6% | +39.8% |
| 5Y | +77.2% | +62.9% | +14.2% | +60.1% |
| All | +77.2% | +62.8% | +14.4% | +60.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling